%0 Journal Article
%T Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis
%A Jimmy Ren
%A Michael J. Davies
%A Michael Pfeifer
%A Raymond R. Townsend
%A Ujjwala Vijapurkar
%J Archive of "Cardiovascular Diabetology".
%D 2017
%R 10.1186/s12933-017-0511-0
%X Physiologic determinants, such as pulse pressure [difference between systolic blood pressure (SBP) and diastolic BP (DBP)], mean arterial pressure (2/3 DBP + 1/3 SBP), and double product [beats per minute (bpm) กม SBP], are linked to cardiovascular outcomes. The effects of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on pulse pressure, mean arterial pressure, and double product were assessed in patients with type 2 diabetes mellitus (T2DM)
%K Canagliflozin
%K Sodium glucose co-transporter 2 (SGLT2) inhibitor
%K Type 2 diabetes
%K Blood pressure
%K Ambulatory blood pressure monitoring
%K Pulse pressure
%K Mean arterial pressure
%K Double product
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327537/